Ossiam’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.1M Buy
+5,564
New +$1.94M 0.03% 255
2025
Q1
– Sell
-70
Closed -$23K – 621
2024
Q4
$23K Sell
70
-472
-87% -$160K ﹤0.01% 598
2024
Q3
$181K Sell
542
-242
-31% -$76.9K ﹤0.01% 546
2024
Q2
$214K Buy
784
+40
+5% +$11.6K ﹤0.01% 529
2024
Q1
$257K Buy
744
+264
+55% +$86.8K ﹤0.01% 556
2023
Q4
$155K Buy
480
+4
+0.8% +$1.25K ﹤0.01% 604
2023
Q3
$171K Sell
476
-131
-22% -$50.5K ﹤0.01% 611
2023
Q2
$230K Buy
607
+307
+102% +$125K ﹤0.01% 586
2023
Q1
$144K Buy
300
+16
+6% +$7.49K ﹤0.01% 533
2022
Q4
$119K Hold
284
– – ﹤0.01% 545
2022
Q3
$118K Buy
284
+256
+914% +$128K ﹤0.01% 533
2022
Q2
$14K Sell
28
-3,864
-99% -$2.01M ﹤0.01% 406
2022
Q1
$2.19M Buy
3,892
+3,823
+5,541% +$2.3M 0.06% 169
2021
Q4
$52K Buy
69
+48
+229% +$35.9K ﹤0.01% 389
2021
Q3
$16K Hold
21
– – ﹤0.01% 421
2021
Q2
$16K Buy
+21
New +$12.8K ﹤0.01% 426
2021
Q1
– Sell
-1,147
Closed -$669K – 415
2020
Q4
$669K Sell
1,147
-420
-27% -$239K 0.02% 242
2020
Q3
$808K Sell
1,567
-1,268
-45% -$642K 0.03% 208
2020
Q2
$1.28M Buy
+2,835
New +$1.25M 0.08% 149

Other funds holding BIO

Ossiam's BIO Position: Q3 2026 in Review

Ossiam opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 5,564 shares worth $2.1M. The stake represents 0.03% of the portfolio and ranks #255 among its holdings. This is a return to the name: Ossiam previously reported a position in BIO as recently as Q4 2024.

Ossiam first reported a position in BIO in Q2 2020 and has held it in 19 quarters since. The position peaked at $2.19M in Q1 2022. 339 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Ossiam held 5,564 shares of Bio-Rad Laboratories Class A worth $2.1M as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Ossiam position in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.03% of Ossiam's portfolio in Q3 2026, its #255 holding.
  • Ossiam first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and has held it in 19 quarters since.
  • Ossiam's Bio-Rad Laboratories Class A position peaked at $2.19M in Q1 2022.
  • 339 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Ossiam's 13F filing for Q3 2026, filed 13 Nov 2026.